Are you talking about Stelo?
Yes! I think I must be. I didn't realize it was out, but haven't really been checking. Thanks for bringing it up. It looks similar to the Dexcom G7, but I'm not sure if it has things like the ability to share in realtime, the readings with your doctor (On the G7, it uses an app called Clarity to sync with external connections like your doctor and look at insights more)?
Also, one thing I think that would rule it out for just me specifically because I really deal with low, and high blood sugars, even when eating and doing everything I can correctly. But the lows are the dangerous parts. I get frequent lows, very very low especially in the night. It doesn't matter what I eat/drink, it just happens.
But it gets dangerously low, it has gone down into the high 40s, but the G7 will give audible alerts and on the Apple watch (haptics and beeps) when a low downtrend is detected ahead of time so I can wake up and deal with it to bring it back up. It isn't every night, but it is frequent enough to be scary and my doctor has put me on these for that reason.
However, my insurance will only cover them if I was on insulin, which I don't require at this time. So I have to pay out of pocket.
It looks like with the Stelo, you get 30 days or so for around $100. For the G7, it's just a bit more it looks like, but instead each sensor only lasts 10 days so 3 are required for a month. I'd have to look at my last pharmacy bill to remember how much each unit costs, but I think if there was a 3rd in the Stelo, it would bring it to about the same cost.
So clearly Dexcom has found a way to maximize battery much longer on those devices. So I'm just wondering what it's either missing vs G7 or if they are just waiting for the G8 and are milking as much money out of the G7 for now.
And,
another failed G7 sensor this morning!. It was on day 8/10. Not acceptable at all, because this as I was saying has now become the norm, across multiple batches. Something is wrong with the newer G7 sensors they're putting out.
On the
Stelo site it mentions "
Adults (18+ years) not on insulin who have been diagnosed with type 2 diabetes or prediabetes and are not at risk for hypoglycemia, and those interested in tracking their glucose."
Which is where I think it excludes me unfortunately. But thanks for the info. Good to read about it and it should help a lot of people being OTC and also covered under certain health programs.